nodes	percent_of_prediction	percent_of_DWPC	metapath
Canagliflozin—ALB—stomach cancer	0.213	1	CbGaD
Canagliflozin—UGT1A9—Irinotecan—stomach cancer	0.121	0.223	CbGbCtD
Canagliflozin—ABCB1—Mitomycin—stomach cancer	0.0763	0.141	CbGbCtD
Canagliflozin—ABCC2—Irinotecan—stomach cancer	0.0601	0.111	CbGbCtD
Canagliflozin—ABCC2—Docetaxel—stomach cancer	0.044	0.0814	CbGbCtD
Canagliflozin—ALB—Irinotecan—stomach cancer	0.0374	0.0692	CbGbCtD
Canagliflozin—ALB—Fluorouracil—stomach cancer	0.0359	0.0665	CbGbCtD
Canagliflozin—ABCC2—Doxorubicin—stomach cancer	0.0328	0.0607	CbGbCtD
Canagliflozin—ABCC2—Methotrexate—stomach cancer	0.0318	0.0588	CbGbCtD
Canagliflozin—ALB—Methotrexate—stomach cancer	0.0198	0.0366	CbGbCtD
Canagliflozin—ABCB1—Irinotecan—stomach cancer	0.0196	0.0362	CbGbCtD
Canagliflozin—ABCB1—Docetaxel—stomach cancer	0.0144	0.0265	CbGbCtD
Canagliflozin—CYP3A4—Irinotecan—stomach cancer	0.0117	0.0217	CbGbCtD
Canagliflozin—ABCB1—Doxorubicin—stomach cancer	0.0107	0.0198	CbGbCtD
Canagliflozin—ABCB1—Methotrexate—stomach cancer	0.0104	0.0192	CbGbCtD
Canagliflozin—ORM1—bile—stomach cancer	0.0103	0.168	CbGeAlD
Canagliflozin—CYP3A4—Docetaxel—stomach cancer	0.0086	0.0159	CbGbCtD
Canagliflozin—ABCC2—bile—stomach cancer	0.0085	0.138	CbGeAlD
Canagliflozin—CYP3A4—Doxorubicin—stomach cancer	0.00641	0.0119	CbGbCtD
Canagliflozin—SLC5A1—epithelium—stomach cancer	0.00449	0.073	CbGeAlD
Canagliflozin—SLC5A2—endocrine gland—stomach cancer	0.00372	0.0606	CbGeAlD
Canagliflozin—Dapagliflozin—CYP2A6—stomach cancer	0.00343	1	CrCbGaD
Canagliflozin—SLC5A1—digestive system—stomach cancer	0.00341	0.0556	CbGeAlD
Canagliflozin—ORM1—gall bladder—stomach cancer	0.00287	0.0468	CbGeAlD
Canagliflozin—UGT2B4—endocrine gland—stomach cancer	0.0026	0.0423	CbGeAlD
Canagliflozin—ALB—gall bladder—stomach cancer	0.00252	0.041	CbGeAlD
Canagliflozin—UGT2B4—liver—stomach cancer	0.00234	0.0381	CbGeAlD
Canagliflozin—UGT1A9—digestive system—stomach cancer	0.00215	0.035	CbGeAlD
Canagliflozin—UGT1A9—endocrine gland—stomach cancer	0.00177	0.0289	CbGeAlD
Canagliflozin—ORM1—hematopoietic system—stomach cancer	0.00163	0.0265	CbGeAlD
Canagliflozin—UGT1A9—liver—stomach cancer	0.0016	0.026	CbGeAlD
Canagliflozin—ORM1—bone marrow—stomach cancer	0.00104	0.017	CbGeAlD
Canagliflozin—ORM1—endocrine gland—stomach cancer	0.000934	0.0152	CbGeAlD
Canagliflozin—ABCC2—digestive system—stomach cancer	0.000929	0.0151	CbGeAlD
Canagliflozin—ABCB1—blood vessel—stomach cancer	0.000902	0.0147	CbGeAlD
Canagliflozin—ORM1—liver—stomach cancer	0.000842	0.0137	CbGeAlD
Canagliflozin—ABCC2—endocrine gland—stomach cancer	0.000767	0.0125	CbGeAlD
Canagliflozin—ALB—liver—stomach cancer	0.000738	0.012	CbGeAlD
Canagliflozin—ABCC2—liver—stomach cancer	0.000692	0.0113	CbGeAlD
Canagliflozin—CYP3A4—hematopoietic system—stomach cancer	0.000678	0.011	CbGeAlD
Canagliflozin—ORM1—lymph node—stomach cancer	0.000646	0.0105	CbGeAlD
Canagliflozin—Serum creatinine increased—Doxorubicin—stomach cancer	0.000583	0.00604	CcSEcCtD
Canagliflozin—ALB—lymph node—stomach cancer	0.000566	0.00922	CbGeAlD
Canagliflozin—Blood creatinine increased—Irinotecan—stomach cancer	0.000565	0.00586	CcSEcCtD
Canagliflozin—Dehydration—Irinotecan—stomach cancer	0.000561	0.00582	CcSEcCtD
Canagliflozin—Orthostatic hypotension—Irinotecan—stomach cancer	0.000551	0.00571	CcSEcCtD
Canagliflozin—Rash—Floxuridine—stomach cancer	0.000549	0.00569	CcSEcCtD
Canagliflozin—Dermatitis—Floxuridine—stomach cancer	0.000548	0.00568	CcSEcCtD
Canagliflozin—ABCC2—lymph node—stomach cancer	0.00053	0.00864	CbGeAlD
Canagliflozin—Nausea—Floxuridine—stomach cancer	0.000517	0.00536	CcSEcCtD
Canagliflozin—Pancreatitis—Irinotecan—stomach cancer	0.000511	0.0053	CcSEcCtD
Canagliflozin—Rash erythematous—Epirubicin—stomach cancer	0.000506	0.00525	CcSEcCtD
Canagliflozin—Urine output increased—Capecitabine—stomach cancer	0.000503	0.00521	CcSEcCtD
Canagliflozin—Asthenia—Mitomycin—stomach cancer	0.00049	0.00508	CcSEcCtD
Canagliflozin—Rash pustular—Epirubicin—stomach cancer	0.000486	0.00504	CcSEcCtD
Canagliflozin—ABCB1—hematopoietic system—stomach cancer	0.00048	0.00782	CbGeAlD
Canagliflozin—CYP3A4—digestive system—stomach cancer	0.000472	0.00768	CbGeAlD
Canagliflozin—Rash erythematous—Doxorubicin—stomach cancer	0.000468	0.00486	CcSEcCtD
Canagliflozin—Diabetes mellitus—Capecitabine—stomach cancer	0.000464	0.00481	CcSEcCtD
Canagliflozin—Polyuria—Capecitabine—stomach cancer	0.00046	0.00477	CcSEcCtD
Canagliflozin—Photosensitivity—Capecitabine—stomach cancer	0.00046	0.00477	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Fluorouracil—stomach cancer	0.000456	0.00473	CcSEcCtD
Canagliflozin—Dizziness—Mitomycin—stomach cancer	0.000452	0.00468	CcSEcCtD
Canagliflozin—Rash pustular—Doxorubicin—stomach cancer	0.00045	0.00466	CcSEcCtD
Canagliflozin—ABCB1—epithelium—stomach cancer	0.000439	0.00715	CbGeAlD
Canagliflozin—Renal failure acute—Capecitabine—stomach cancer	0.000438	0.00453	CcSEcCtD
Canagliflozin—Urinary tract infection—Fluorouracil—stomach cancer	0.000433	0.00449	CcSEcCtD
Canagliflozin—Rash—Mitomycin—stomach cancer	0.000431	0.00446	CcSEcCtD
Canagliflozin—Dermatitis—Mitomycin—stomach cancer	0.00043	0.00446	CcSEcCtD
Canagliflozin—Thirst—Capecitabine—stomach cancer	0.000424	0.0044	CcSEcCtD
Canagliflozin—Nocturia—Epirubicin—stomach cancer	0.000418	0.00433	CcSEcCtD
Canagliflozin—Nausea—Mitomycin—stomach cancer	0.000406	0.00421	CcSEcCtD
Canagliflozin—Cystitis noninfective—Methotrexate—stomach cancer	0.000405	0.00419	CcSEcCtD
Canagliflozin—Cystitis—Methotrexate—stomach cancer	0.0004	0.00415	CcSEcCtD
Canagliflozin—Vaginal infection—Methotrexate—stomach cancer	0.000391	0.00405	CcSEcCtD
Canagliflozin—ABCB1—pancreas—stomach cancer	0.000391	0.00637	CbGeAlD
Canagliflozin—CYP3A4—endocrine gland—stomach cancer	0.00039	0.00635	CbGeAlD
Canagliflozin—Dehydration—Docetaxel—stomach cancer	0.000388	0.00402	CcSEcCtD
Canagliflozin—Nocturia—Doxorubicin—stomach cancer	0.000387	0.00401	CcSEcCtD
Canagliflozin—Orthostatic hypotension—Docetaxel—stomach cancer	0.000381	0.00395	CcSEcCtD
Canagliflozin—Hyperkalaemia—Epirubicin—stomach cancer	0.000381	0.00395	CcSEcCtD
Canagliflozin—Angiopathy—Irinotecan—stomach cancer	0.000379	0.00393	CcSEcCtD
Canagliflozin—Cystitis noninfective—Epirubicin—stomach cancer	0.000379	0.00392	CcSEcCtD
Canagliflozin—Blood creatinine increased—Capecitabine—stomach cancer	0.000378	0.00392	CcSEcCtD
Canagliflozin—Breast disorder—Docetaxel—stomach cancer	0.000377	0.00391	CcSEcCtD
Canagliflozin—Dehydration—Capecitabine—stomach cancer	0.000376	0.00389	CcSEcCtD
Canagliflozin—Bladder pain—Methotrexate—stomach cancer	0.000375	0.00388	CcSEcCtD
Canagliflozin—Urine output increased—Methotrexate—stomach cancer	0.000375	0.00388	CcSEcCtD
Canagliflozin—Cystitis—Epirubicin—stomach cancer	0.000374	0.00388	CcSEcCtD
Canagliflozin—Orthostatic hypotension—Capecitabine—stomach cancer	0.000369	0.00382	CcSEcCtD
Canagliflozin—Blood urea increased—Epirubicin—stomach cancer	0.000366	0.00379	CcSEcCtD
Canagliflozin—Vaginal infection—Epirubicin—stomach cancer	0.000366	0.00379	CcSEcCtD
Canagliflozin—Breast disorder—Capecitabine—stomach cancer	0.000365	0.00378	CcSEcCtD
Canagliflozin—Hyperkalaemia—Doxorubicin—stomach cancer	0.000352	0.00365	CcSEcCtD
Canagliflozin—Rash maculo-papular—Epirubicin—stomach cancer	0.000352	0.00365	CcSEcCtD
Canagliflozin—CYP3A4—liver—stomach cancer	0.000351	0.00572	CbGeAlD
Canagliflozin—Bladder pain—Epirubicin—stomach cancer	0.000351	0.00363	CcSEcCtD
Canagliflozin—Cystitis noninfective—Doxorubicin—stomach cancer	0.00035	0.00363	CcSEcCtD
Canagliflozin—Erythema—Fluorouracil—stomach cancer	0.000348	0.00361	CcSEcCtD
Canagliflozin—Cystitis—Doxorubicin—stomach cancer	0.000346	0.00359	CcSEcCtD
Canagliflozin—Diabetes mellitus—Methotrexate—stomach cancer	0.000346	0.00358	CcSEcCtD
Canagliflozin—Polyuria—Methotrexate—stomach cancer	0.000342	0.00355	CcSEcCtD
Canagliflozin—Photosensitivity—Methotrexate—stomach cancer	0.000342	0.00355	CcSEcCtD
Canagliflozin—Blood urea increased—Doxorubicin—stomach cancer	0.000339	0.00351	CcSEcCtD
Canagliflozin—Vaginal infection—Doxorubicin—stomach cancer	0.000339	0.00351	CcSEcCtD
Canagliflozin—ABCB1—lymphoid tissue—stomach cancer	0.000338	0.0055	CbGeAlD
Canagliflozin—ABCB1—digestive system—stomach cancer	0.000334	0.00544	CbGeAlD
Canagliflozin—Rash maculo-papular—Doxorubicin—stomach cancer	0.000326	0.00338	CcSEcCtD
Canagliflozin—Syncope—Irinotecan—stomach cancer	0.000326	0.00338	CcSEcCtD
Canagliflozin—Renal failure acute—Methotrexate—stomach cancer	0.000326	0.00338	CcSEcCtD
Canagliflozin—Bladder pain—Doxorubicin—stomach cancer	0.000324	0.00336	CcSEcCtD
Canagliflozin—Diabetes mellitus—Epirubicin—stomach cancer	0.000324	0.00335	CcSEcCtD
Canagliflozin—Photosensitivity—Epirubicin—stomach cancer	0.00032	0.00332	CcSEcCtD
Canagliflozin—Loss of consciousness—Irinotecan—stomach cancer	0.000319	0.00331	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Capecitabine—stomach cancer	0.000319	0.0033	CcSEcCtD
Canagliflozin—ABCB1—bone marrow—stomach cancer	0.000308	0.00501	CbGeAlD
Canagliflozin—Renal failure acute—Epirubicin—stomach cancer	0.000305	0.00316	CcSEcCtD
Canagliflozin—Urinary tract infection—Capecitabine—stomach cancer	0.000303	0.00314	CcSEcCtD
Canagliflozin—Convulsion—Fluorouracil—stomach cancer	0.000302	0.00313	CcSEcCtD
Canagliflozin—Diabetes mellitus—Doxorubicin—stomach cancer	0.000299	0.0031	CcSEcCtD
Canagliflozin—Photosensitivity—Doxorubicin—stomach cancer	0.000297	0.00307	CcSEcCtD
Canagliflozin—Infection—Irinotecan—stomach cancer	0.000295	0.00305	CcSEcCtD
Canagliflozin—Shock—Irinotecan—stomach cancer	0.000292	0.00302	CcSEcCtD
Canagliflozin—Nervous system disorder—Irinotecan—stomach cancer	0.000291	0.00302	CcSEcCtD
Canagliflozin—Hypoglycaemia—Epirubicin—stomach cancer	0.000288	0.00299	CcSEcCtD
Canagliflozin—Urinary tract disorder—Docetaxel—stomach cancer	0.000285	0.00295	CcSEcCtD
Canagliflozin—Urethral disorder—Docetaxel—stomach cancer	0.000283	0.00293	CcSEcCtD
Canagliflozin—Infection—Fluorouracil—stomach cancer	0.000282	0.00293	CcSEcCtD
Canagliflozin—Renal failure acute—Doxorubicin—stomach cancer	0.000282	0.00292	CcSEcCtD
Canagliflozin—Nervous system disorder—Fluorouracil—stomach cancer	0.000279	0.00289	CcSEcCtD
Canagliflozin—Hypotension—Irinotecan—stomach cancer	0.000277	0.00287	CcSEcCtD
Canagliflozin—Urinary tract disorder—Capecitabine—stomach cancer	0.000276	0.00286	CcSEcCtD
Canagliflozin—ABCB1—endocrine gland—stomach cancer	0.000276	0.00449	CbGeAlD
Canagliflozin—Urethral disorder—Capecitabine—stomach cancer	0.000274	0.00284	CcSEcCtD
Canagliflozin—Breast disorder—Methotrexate—stomach cancer	0.000272	0.00282	CcSEcCtD
Canagliflozin—Hypoglycaemia—Doxorubicin—stomach cancer	0.000267	0.00277	CcSEcCtD
Canagliflozin—Hypotension—Fluorouracil—stomach cancer	0.000265	0.00275	CcSEcCtD
Canagliflozin—Blood creatinine increased—Epirubicin—stomach cancer	0.000264	0.00273	CcSEcCtD
Canagliflozin—Angiopathy—Docetaxel—stomach cancer	0.000262	0.00271	CcSEcCtD
Canagliflozin—Dehydration—Epirubicin—stomach cancer	0.000262	0.00271	CcSEcCtD
Canagliflozin—Orthostatic hypotension—Epirubicin—stomach cancer	0.000257	0.00266	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000256	0.00265	CcSEcCtD
Canagliflozin—Fatigue—Irinotecan—stomach cancer	0.000256	0.00265	CcSEcCtD
Canagliflozin—Pancreatitis—Methotrexate—stomach cancer	0.000255	0.00264	CcSEcCtD
Canagliflozin—Breast disorder—Epirubicin—stomach cancer	0.000254	0.00264	CcSEcCtD
Canagliflozin—Constipation—Irinotecan—stomach cancer	0.000254	0.00263	CcSEcCtD
Canagliflozin—Angiopathy—Capecitabine—stomach cancer	0.000254	0.00263	CcSEcCtD
Canagliflozin—Erythema—Docetaxel—stomach cancer	0.000251	0.0026	CcSEcCtD
Canagliflozin—Malnutrition—Docetaxel—stomach cancer	0.000251	0.0026	CcSEcCtD
Canagliflozin—ABCB1—liver—stomach cancer	0.000249	0.00405	CbGeAlD
Canagliflozin—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000245	0.00254	CcSEcCtD
Canagliflozin—Blood creatinine increased—Doxorubicin—stomach cancer	0.000244	0.00253	CcSEcCtD
Canagliflozin—Erythema—Capecitabine—stomach cancer	0.000243	0.00252	CcSEcCtD
Canagliflozin—Malnutrition—Capecitabine—stomach cancer	0.000243	0.00252	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Irinotecan—stomach cancer	0.000243	0.00251	CcSEcCtD
Canagliflozin—Dehydration—Doxorubicin—stomach cancer	0.000242	0.00251	CcSEcCtD
Canagliflozin—Pancreatitis—Epirubicin—stomach cancer	0.000238	0.00247	CcSEcCtD
Canagliflozin—Orthostatic hypotension—Doxorubicin—stomach cancer	0.000238	0.00246	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Methotrexate—stomach cancer	0.000237	0.00246	CcSEcCtD
Canagliflozin—Breast disorder—Doxorubicin—stomach cancer	0.000235	0.00244	CcSEcCtD
Canagliflozin—Abdominal pain—Irinotecan—stomach cancer	0.000234	0.00243	CcSEcCtD
Canagliflozin—Urticaria—Fluorouracil—stomach cancer	0.000226	0.00234	CcSEcCtD
Canagliflozin—Syncope—Docetaxel—stomach cancer	0.000225	0.00234	CcSEcCtD
Canagliflozin—Pollakiuria—Epirubicin—stomach cancer	0.000225	0.00233	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Epirubicin—stomach cancer	0.000222	0.0023	CcSEcCtD
Canagliflozin—Loss of consciousness—Docetaxel—stomach cancer	0.000221	0.00229	CcSEcCtD
Canagliflozin—Pancreatitis—Doxorubicin—stomach cancer	0.000221	0.00229	CcSEcCtD
Canagliflozin—Hypersensitivity—Irinotecan—stomach cancer	0.000219	0.00227	CcSEcCtD
Canagliflozin—Syncope—Capecitabine—stomach cancer	0.000218	0.00226	CcSEcCtD
Canagliflozin—Convulsion—Docetaxel—stomach cancer	0.000218	0.00226	CcSEcCtD
Canagliflozin—Loss of consciousness—Capecitabine—stomach cancer	0.000214	0.00222	CcSEcCtD
Canagliflozin—Asthenia—Irinotecan—stomach cancer	0.000213	0.00221	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000212	0.0022	CcSEcCtD
Canagliflozin—Urinary tract infection—Epirubicin—stomach cancer	0.000211	0.00218	CcSEcCtD
Canagliflozin—Hypersensitivity—Fluorouracil—stomach cancer	0.000209	0.00217	CcSEcCtD
Canagliflozin—Dry mouth—Docetaxel—stomach cancer	0.000209	0.00217	CcSEcCtD
Canagliflozin—Pollakiuria—Doxorubicin—stomach cancer	0.000208	0.00215	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000206	0.00213	CcSEcCtD
Canagliflozin—Urinary tract disorder—Methotrexate—stomach cancer	0.000205	0.00213	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Doxorubicin—stomach cancer	0.000205	0.00213	CcSEcCtD
Canagliflozin—Urethral disorder—Methotrexate—stomach cancer	0.000204	0.00211	CcSEcCtD
Canagliflozin—Infection—Docetaxel—stomach cancer	0.000204	0.00211	CcSEcCtD
Canagliflozin—Dry mouth—Capecitabine—stomach cancer	0.000203	0.0021	CcSEcCtD
Canagliflozin—Shock—Docetaxel—stomach cancer	0.000202	0.00209	CcSEcCtD
Canagliflozin—Nervous system disorder—Docetaxel—stomach cancer	0.000201	0.00208	CcSEcCtD
Canagliflozin—Pruritus—Fluorouracil—stomach cancer	0.000201	0.00208	CcSEcCtD
Canagliflozin—Skin disorder—Docetaxel—stomach cancer	0.000199	0.00206	CcSEcCtD
Canagliflozin—Infection—Capecitabine—stomach cancer	0.000197	0.00204	CcSEcCtD
Canagliflozin—Dizziness—Irinotecan—stomach cancer	0.000196	0.00203	CcSEcCtD
Canagliflozin—Shock—Capecitabine—stomach cancer	0.000195	0.00202	CcSEcCtD
Canagliflozin—Urinary tract infection—Doxorubicin—stomach cancer	0.000195	0.00202	CcSEcCtD
Canagliflozin—Nervous system disorder—Capecitabine—stomach cancer	0.000195	0.00202	CcSEcCtD
Canagliflozin—Skin disorder—Capecitabine—stomach cancer	0.000193	0.002	CcSEcCtD
Canagliflozin—Urinary tract disorder—Epirubicin—stomach cancer	0.000192	0.00199	CcSEcCtD
Canagliflozin—Hypotension—Docetaxel—stomach cancer	0.000192	0.00199	CcSEcCtD
Canagliflozin—Urethral disorder—Epirubicin—stomach cancer	0.000191	0.00198	CcSEcCtD
Canagliflozin—ABCB1—lymph node—stomach cancer	0.000191	0.00311	CbGeAlD
Canagliflozin—Angiopathy—Methotrexate—stomach cancer	0.000189	0.00196	CcSEcCtD
Canagliflozin—Dizziness—Fluorouracil—stomach cancer	0.000188	0.00195	CcSEcCtD
Canagliflozin—Rash—Irinotecan—stomach cancer	0.000187	0.00194	CcSEcCtD
Canagliflozin—Dermatitis—Irinotecan—stomach cancer	0.000187	0.00194	CcSEcCtD
Canagliflozin—Hypotension—Capecitabine—stomach cancer	0.000186	0.00192	CcSEcCtD
Canagliflozin—Malnutrition—Methotrexate—stomach cancer	0.000181	0.00188	CcSEcCtD
Canagliflozin—Erythema—Methotrexate—stomach cancer	0.000181	0.00188	CcSEcCtD
Canagliflozin—Rash—Fluorouracil—stomach cancer	0.000179	0.00186	CcSEcCtD
Canagliflozin—Dermatitis—Fluorouracil—stomach cancer	0.000179	0.00186	CcSEcCtD
Canagliflozin—Urinary tract disorder—Doxorubicin—stomach cancer	0.000178	0.00184	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000177	0.00183	CcSEcCtD
Canagliflozin—Fatigue—Docetaxel—stomach cancer	0.000177	0.00183	CcSEcCtD
Canagliflozin—Angiopathy—Epirubicin—stomach cancer	0.000177	0.00183	CcSEcCtD
Canagliflozin—Urethral disorder—Doxorubicin—stomach cancer	0.000177	0.00183	CcSEcCtD
Canagliflozin—Nausea—Irinotecan—stomach cancer	0.000176	0.00183	CcSEcCtD
Canagliflozin—Constipation—Docetaxel—stomach cancer	0.000175	0.00182	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000171	0.00178	CcSEcCtD
Canagliflozin—Fatigue—Capecitabine—stomach cancer	0.000171	0.00177	CcSEcCtD
Canagliflozin—Constipation—Capecitabine—stomach cancer	0.00017	0.00176	CcSEcCtD
Canagliflozin—Malnutrition—Epirubicin—stomach cancer	0.000169	0.00176	CcSEcCtD
Canagliflozin—Erythema—Epirubicin—stomach cancer	0.000169	0.00176	CcSEcCtD
Canagliflozin—Nausea—Fluorouracil—stomach cancer	0.000169	0.00175	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Docetaxel—stomach cancer	0.000168	0.00174	CcSEcCtD
Canagliflozin—Angiopathy—Doxorubicin—stomach cancer	0.000163	0.00169	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Capecitabine—stomach cancer	0.000162	0.00168	CcSEcCtD
Canagliflozin—Abdominal pain—Docetaxel—stomach cancer	0.000162	0.00168	CcSEcCtD
Canagliflozin—Urticaria—Capecitabine—stomach cancer	0.000158	0.00163	CcSEcCtD
Canagliflozin—Abdominal pain—Capecitabine—stomach cancer	0.000157	0.00163	CcSEcCtD
Canagliflozin—Convulsion—Methotrexate—stomach cancer	0.000157	0.00163	CcSEcCtD
Canagliflozin—Malnutrition—Doxorubicin—stomach cancer	0.000157	0.00163	CcSEcCtD
Canagliflozin—Erythema—Doxorubicin—stomach cancer	0.000157	0.00163	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000153	0.00159	CcSEcCtD
Canagliflozin—Syncope—Epirubicin—stomach cancer	0.000152	0.00158	CcSEcCtD
Canagliflozin—Hypersensitivity—Docetaxel—stomach cancer	0.000151	0.00157	CcSEcCtD
Canagliflozin—Loss of consciousness—Epirubicin—stomach cancer	0.000149	0.00154	CcSEcCtD
Canagliflozin—Asthenia—Docetaxel—stomach cancer	0.000147	0.00152	CcSEcCtD
Canagliflozin—Convulsion—Epirubicin—stomach cancer	0.000147	0.00152	CcSEcCtD
Canagliflozin—Infection—Methotrexate—stomach cancer	0.000147	0.00152	CcSEcCtD
Canagliflozin—Hypersensitivity—Capecitabine—stomach cancer	0.000146	0.00152	CcSEcCtD
Canagliflozin—Pruritus—Docetaxel—stomach cancer	0.000145	0.0015	CcSEcCtD
Canagliflozin—Nervous system disorder—Methotrexate—stomach cancer	0.000145	0.0015	CcSEcCtD
Canagliflozin—Skin disorder—Methotrexate—stomach cancer	0.000144	0.00149	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000143	0.00149	CcSEcCtD
Canagliflozin—Asthenia—Capecitabine—stomach cancer	0.000142	0.00148	CcSEcCtD
Canagliflozin—Dry mouth—Epirubicin—stomach cancer	0.000141	0.00146	CcSEcCtD
Canagliflozin—Syncope—Doxorubicin—stomach cancer	0.000141	0.00146	CcSEcCtD
Canagliflozin—Pruritus—Capecitabine—stomach cancer	0.00014	0.00146	CcSEcCtD
Canagliflozin—Hypotension—Methotrexate—stomach cancer	0.000138	0.00143	CcSEcCtD
Canagliflozin—Loss of consciousness—Doxorubicin—stomach cancer	0.000138	0.00143	CcSEcCtD
Canagliflozin—Infection—Epirubicin—stomach cancer	0.000137	0.00142	CcSEcCtD
Canagliflozin—Shock—Epirubicin—stomach cancer	0.000136	0.00141	CcSEcCtD
Canagliflozin—Convulsion—Doxorubicin—stomach cancer	0.000136	0.00141	CcSEcCtD
Canagliflozin—Nervous system disorder—Epirubicin—stomach cancer	0.000136	0.00141	CcSEcCtD
Canagliflozin—Dizziness—Docetaxel—stomach cancer	0.000136	0.00141	CcSEcCtD
Canagliflozin—Skin disorder—Epirubicin—stomach cancer	0.000134	0.00139	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000133	0.00137	CcSEcCtD
Canagliflozin—Dizziness—Capecitabine—stomach cancer	0.000131	0.00136	CcSEcCtD
Canagliflozin—Dry mouth—Doxorubicin—stomach cancer	0.000131	0.00135	CcSEcCtD
Canagliflozin—Rash—Docetaxel—stomach cancer	0.000129	0.00134	CcSEcCtD
Canagliflozin—Hypotension—Epirubicin—stomach cancer	0.000129	0.00134	CcSEcCtD
Canagliflozin—Dermatitis—Docetaxel—stomach cancer	0.000129	0.00134	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000128	0.00132	CcSEcCtD
Canagliflozin—Fatigue—Methotrexate—stomach cancer	0.000127	0.00132	CcSEcCtD
Canagliflozin—Infection—Doxorubicin—stomach cancer	0.000127	0.00132	CcSEcCtD
Canagliflozin—Shock—Doxorubicin—stomach cancer	0.000126	0.00131	CcSEcCtD
Canagliflozin—Nervous system disorder—Doxorubicin—stomach cancer	0.000126	0.0013	CcSEcCtD
Canagliflozin—Rash—Capecitabine—stomach cancer	0.000125	0.0013	CcSEcCtD
Canagliflozin—Dermatitis—Capecitabine—stomach cancer	0.000125	0.0013	CcSEcCtD
Canagliflozin—Skin disorder—Doxorubicin—stomach cancer	0.000124	0.00129	CcSEcCtD
Canagliflozin—Nausea—Docetaxel—stomach cancer	0.000122	0.00126	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Methotrexate—stomach cancer	0.000121	0.00125	CcSEcCtD
Canagliflozin—Hypotension—Doxorubicin—stomach cancer	0.00012	0.00124	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000119	0.00124	CcSEcCtD
Canagliflozin—Fatigue—Epirubicin—stomach cancer	0.000119	0.00124	CcSEcCtD
Canagliflozin—Constipation—Epirubicin—stomach cancer	0.000118	0.00123	CcSEcCtD
Canagliflozin—Nausea—Capecitabine—stomach cancer	0.000118	0.00122	CcSEcCtD
Canagliflozin—Urticaria—Methotrexate—stomach cancer	0.000117	0.00122	CcSEcCtD
Canagliflozin—Abdominal pain—Methotrexate—stomach cancer	0.000117	0.00121	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Epirubicin—stomach cancer	0.000113	0.00117	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.00011	0.00115	CcSEcCtD
Canagliflozin—Fatigue—Doxorubicin—stomach cancer	0.00011	0.00114	CcSEcCtD
Canagliflozin—Urticaria—Epirubicin—stomach cancer	0.00011	0.00114	CcSEcCtD
Canagliflozin—Constipation—Doxorubicin—stomach cancer	0.000109	0.00113	CcSEcCtD
Canagliflozin—Abdominal pain—Epirubicin—stomach cancer	0.000109	0.00113	CcSEcCtD
Canagliflozin—Hypersensitivity—Methotrexate—stomach cancer	0.000109	0.00113	CcSEcCtD
Canagliflozin—Asthenia—Methotrexate—stomach cancer	0.000106	0.0011	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000105	0.00108	CcSEcCtD
Canagliflozin—Pruritus—Methotrexate—stomach cancer	0.000105	0.00108	CcSEcCtD
Canagliflozin—Hypersensitivity—Epirubicin—stomach cancer	0.000102	0.00106	CcSEcCtD
Canagliflozin—Urticaria—Doxorubicin—stomach cancer	0.000102	0.00105	CcSEcCtD
Canagliflozin—Abdominal pain—Doxorubicin—stomach cancer	0.000101	0.00105	CcSEcCtD
Canagliflozin—Asthenia—Epirubicin—stomach cancer	9.92e-05	0.00103	CcSEcCtD
Canagliflozin—Pruritus—Epirubicin—stomach cancer	9.79e-05	0.00101	CcSEcCtD
Canagliflozin—Dizziness—Methotrexate—stomach cancer	9.77e-05	0.00101	CcSEcCtD
Canagliflozin—Hypersensitivity—Doxorubicin—stomach cancer	9.43e-05	0.000977	CcSEcCtD
Canagliflozin—Rash—Methotrexate—stomach cancer	9.32e-05	0.000966	CcSEcCtD
Canagliflozin—Dermatitis—Methotrexate—stomach cancer	9.31e-05	0.000965	CcSEcCtD
Canagliflozin—Asthenia—Doxorubicin—stomach cancer	9.18e-05	0.000952	CcSEcCtD
Canagliflozin—Dizziness—Epirubicin—stomach cancer	9.15e-05	0.000948	CcSEcCtD
Canagliflozin—Pruritus—Doxorubicin—stomach cancer	9.05e-05	0.000938	CcSEcCtD
Canagliflozin—Nausea—Methotrexate—stomach cancer	8.78e-05	0.00091	CcSEcCtD
Canagliflozin—Rash—Epirubicin—stomach cancer	8.72e-05	0.000904	CcSEcCtD
Canagliflozin—Dermatitis—Epirubicin—stomach cancer	8.71e-05	0.000903	CcSEcCtD
Canagliflozin—Dizziness—Doxorubicin—stomach cancer	8.46e-05	0.000877	CcSEcCtD
Canagliflozin—Nausea—Epirubicin—stomach cancer	8.22e-05	0.000852	CcSEcCtD
Canagliflozin—Rash—Doxorubicin—stomach cancer	8.07e-05	0.000836	CcSEcCtD
Canagliflozin—Dermatitis—Doxorubicin—stomach cancer	8.06e-05	0.000836	CcSEcCtD
Canagliflozin—Nausea—Doxorubicin—stomach cancer	7.6e-05	0.000788	CcSEcCtD
Canagliflozin—SLC5A2—Metabolism—PTGS2—stomach cancer	2.92e-05	0.000342	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	2.88e-05	0.000337	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—PRKCB—stomach cancer	2.88e-05	0.000337	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ALDOB—stomach cancer	2.87e-05	0.000336	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—IRF1—stomach cancer	2.87e-05	0.000336	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PPARG—stomach cancer	2.86e-05	0.000335	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PGLS—stomach cancer	2.86e-05	0.000335	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—BLVRB—stomach cancer	2.86e-05	0.000335	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—TNF—stomach cancer	2.81e-05	0.000329	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NDUFS1—stomach cancer	2.81e-05	0.000329	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NDUFV1—stomach cancer	2.81e-05	0.000329	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PPAP2A—stomach cancer	2.73e-05	0.00032	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—STAT3—stomach cancer	2.72e-05	0.000318	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—STAT3—stomach cancer	2.72e-05	0.000318	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	2.71e-05	0.000317	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.71e-05	0.000317	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.7e-05	0.000316	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ALOX5—stomach cancer	2.67e-05	0.000312	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—GSTP1—stomach cancer	2.66e-05	0.000311	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—DPYD—stomach cancer	2.63e-05	0.000307	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	2.63e-05	0.000307	CbGpPWpGaD
Canagliflozin—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	2.62e-05	0.000307	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—MAPK3—stomach cancer	2.6e-05	0.000304	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—MAPK3—stomach cancer	2.6e-05	0.000304	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ALB—stomach cancer	2.58e-05	0.000301	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—MYC—stomach cancer	2.53e-05	0.000296	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—MYC—stomach cancer	2.53e-05	0.000296	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	2.52e-05	0.000295	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—BLVRB—stomach cancer	2.51e-05	0.000294	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PGLS—stomach cancer	2.51e-05	0.000294	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—APOA1—stomach cancer	2.51e-05	0.000293	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—CD44—stomach cancer	2.49e-05	0.000292	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—MAPK1—stomach cancer	2.47e-05	0.000289	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—MAPK1—stomach cancer	2.47e-05	0.000289	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—EGFR—stomach cancer	2.47e-05	0.000289	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—EGFR—stomach cancer	2.47e-05	0.000289	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—NOS3—stomach cancer	2.46e-05	0.000288	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—GSTM1—stomach cancer	2.44e-05	0.000286	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—FBP1—stomach cancer	2.43e-05	0.000285	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CKB—stomach cancer	2.43e-05	0.000285	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—NDUFA2—stomach cancer	2.43e-05	0.000285	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CA1—stomach cancer	2.43e-05	0.000285	CbGpPWpGaD
Canagliflozin—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	2.41e-05	0.000282	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—SERPINE1—stomach cancer	2.39e-05	0.00028	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PPAP2A—stomach cancer	2.39e-05	0.00028	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.38e-05	0.000279	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—IL6—stomach cancer	2.38e-05	0.000278	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—KRAS—stomach cancer	2.33e-05	0.000273	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—KRAS—stomach cancer	2.33e-05	0.000273	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GSTT1—stomach cancer	2.32e-05	0.000272	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—RHOA—stomach cancer	2.31e-05	0.00027	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CYP2A6—stomach cancer	2.3e-05	0.000269	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PLIN2—stomach cancer	2.29e-05	0.000268	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ACAD8—stomach cancer	2.29e-05	0.000268	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PTGS2—stomach cancer	2.25e-05	0.000264	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—AKR1C3—stomach cancer	2.23e-05	0.000261	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CA2—stomach cancer	2.23e-05	0.000261	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ENO1—stomach cancer	2.18e-05	0.000255	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—NT5E—stomach cancer	2.17e-05	0.000254	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PGAM1—stomach cancer	2.17e-05	0.000254	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—PIK3CA—stomach cancer	2.14e-05	0.000251	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—PIK3CA—stomach cancer	2.14e-05	0.000251	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.14e-05	0.000251	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CA1—stomach cancer	2.13e-05	0.00025	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NDUFA2—stomach cancer	2.13e-05	0.00025	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—FBP1—stomach cancer	2.13e-05	0.00025	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CKB—stomach cancer	2.13e-05	0.00025	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PPP2R1A—stomach cancer	2.12e-05	0.000248	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	2.1e-05	0.000246	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PLCE1—stomach cancer	2.07e-05	0.000242	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ALDH7A1—stomach cancer	2.07e-05	0.000242	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	2.06e-05	0.000241	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GMPR2—stomach cancer	2.04e-05	0.000239	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PLIN2—stomach cancer	2e-05	0.000235	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—ALB—stomach cancer	1.99e-05	0.000232	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—UMPS—stomach cancer	1.98e-05	0.000232	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—HRAS—stomach cancer	1.98e-05	0.000232	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—HRAS—stomach cancer	1.98e-05	0.000232	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CA2—stomach cancer	1.95e-05	0.000228	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	1.95e-05	0.000228	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CD44—stomach cancer	1.93e-05	0.000226	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NT5E—stomach cancer	1.9e-05	0.000222	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PGAM1—stomach cancer	1.9e-05	0.000222	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—IL6—stomach cancer	1.9e-05	0.000222	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—IL6—stomach cancer	1.9e-05	0.000222	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.87e-05	0.000219	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—FYN—stomach cancer	1.87e-05	0.000219	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—IDH3B—stomach cancer	1.86e-05	0.000218	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SUCLG1—stomach cancer	1.86e-05	0.000218	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	1.86e-05	0.000218	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	1.85e-05	0.000217	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PDHA1—stomach cancer	1.84e-05	0.000216	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ECHS1—stomach cancer	1.84e-05	0.000216	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PLCE1—stomach cancer	1.81e-05	0.000212	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ALDH7A1—stomach cancer	1.81e-05	0.000212	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	1.8e-05	0.00021	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PIK3CA—stomach cancer	1.8e-05	0.00021	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PIK3CA—stomach cancer	1.8e-05	0.00021	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.77e-05	0.000208	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	1.76e-05	0.000205	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—UMPS—stomach cancer	1.74e-05	0.000203	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—FADS1—stomach cancer	1.73e-05	0.000203	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—TYMP—stomach cancer	1.73e-05	0.000203	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NDUFV1—stomach cancer	1.73e-05	0.000203	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NDUFS1—stomach cancer	1.73e-05	0.000203	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	1.65e-05	0.000193	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PPP2R1A—stomach cancer	1.64e-05	0.000192	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SREBF2—stomach cancer	1.62e-05	0.00019	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	1.62e-05	0.00019	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PDHA1—stomach cancer	1.62e-05	0.000189	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ECHS1—stomach cancer	1.62e-05	0.000189	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GSTP1—stomach cancer	1.61e-05	0.000188	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—RORA—stomach cancer	1.6e-05	0.000188	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PLAU—stomach cancer	1.59e-05	0.000187	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—HMOX1—stomach cancer	1.59e-05	0.000186	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—CAV1—stomach cancer	1.56e-05	0.000182	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	1.56e-05	0.000182	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.55e-05	0.000182	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—APOA1—stomach cancer	1.55e-05	0.000182	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PGLS—stomach cancer	1.54e-05	0.000181	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—BLVRB—stomach cancer	1.54e-05	0.000181	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.53e-05	0.000179	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—TYMP—stomach cancer	1.52e-05	0.000178	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—FADS1—stomach cancer	1.52e-05	0.000178	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ALDOB—stomach cancer	1.5e-05	0.000176	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—TYMS—stomach cancer	1.5e-05	0.000175	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.49e-05	0.000175	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PRKCB—stomach cancer	1.48e-05	0.000173	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	1.48e-05	0.000173	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GSTM1—stomach cancer	1.48e-05	0.000173	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.47e-05	0.000173	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.46e-05	0.000171	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.46e-05	0.000171	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SREBF2—stomach cancer	1.42e-05	0.000167	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.42e-05	0.000166	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.41e-05	0.000166	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—RORA—stomach cancer	1.41e-05	0.000165	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ALOX5—stomach cancer	1.4e-05	0.000164	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ERCC2—stomach cancer	1.39e-05	0.000163	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.39e-05	0.000163	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PIK3CA—stomach cancer	1.39e-05	0.000162	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.38e-05	0.000161	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—DPYD—stomach cancer	1.38e-05	0.000161	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	1.34e-05	0.000157	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ALDOB—stomach cancer	1.32e-05	0.000154	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CKB—stomach cancer	1.31e-05	0.000154	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CA1—stomach cancer	1.31e-05	0.000154	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.31e-05	0.000154	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—FBP1—stomach cancer	1.31e-05	0.000154	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—MTHFR—stomach cancer	1.31e-05	0.000153	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	1.29e-05	0.00015	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.27e-05	0.000148	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.25e-05	0.000146	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PLIN2—stomach cancer	1.24e-05	0.000145	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—SERPINE1—stomach cancer	1.23e-05	0.000144	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ALOX5—stomach cancer	1.22e-05	0.000143	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.22e-05	0.000143	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GSTT1—stomach cancer	1.22e-05	0.000142	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CAV1—stomach cancer	1.21e-05	0.000141	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—DPYD—stomach cancer	1.2e-05	0.000141	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—APOA1—stomach cancer	1.2e-05	0.000141	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CYP2A6—stomach cancer	1.2e-05	0.000141	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CA2—stomach cancer	1.2e-05	0.000141	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—RHOA—stomach cancer	1.19e-05	0.000139	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	1.18e-05	0.000138	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—NOS3—stomach cancer	1.18e-05	0.000138	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PGAM1—stomach cancer	1.17e-05	0.000137	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NT5E—stomach cancer	1.17e-05	0.000137	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—AKR1C3—stomach cancer	1.17e-05	0.000137	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.15e-05	0.000135	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ENO1—stomach cancer	1.14e-05	0.000133	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.12e-05	0.000131	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PLCE1—stomach cancer	1.12e-05	0.000131	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—UMPS—stomach cancer	1.07e-05	0.000125	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GSTT1—stomach cancer	1.07e-05	0.000125	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PPARG—stomach cancer	1.06e-05	0.000124	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CYP2A6—stomach cancer	1.05e-05	0.000123	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—AKR1C3—stomach cancer	1.02e-05	0.00012	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CD44—stomach cancer	1.01e-05	0.000118	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ENO1—stomach cancer	9.98e-06	0.000117	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PDHA1—stomach cancer	9.96e-06	0.000117	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ECHS1—stomach cancer	9.96e-06	0.000117	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	9.8e-06	0.000115	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ALB—stomach cancer	9.53e-06	0.000112	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—TYMP—stomach cancer	9.36e-06	0.00011	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—FADS1—stomach cancer	9.36e-06	0.00011	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	9.34e-06	0.000109	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—NOS3—stomach cancer	9.12e-06	0.000107	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CD44—stomach cancer	8.85e-06	0.000104	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SREBF2—stomach cancer	8.77e-06	0.000103	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—RORA—stomach cancer	8.66e-06	0.000101	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PPP2R1A—stomach cancer	8.59e-06	0.000101	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—VEGFA—stomach cancer	8.48e-06	9.93e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GSTP1—stomach cancer	8.43e-06	9.86e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PTGS2—stomach cancer	8.34e-06	9.76e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—HMOX1—stomach cancer	8.31e-06	9.73e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ALDOB—stomach cancer	8.12e-06	9.5e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—MAPK3—stomach cancer	8.02e-06	9.39e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—TYMS—stomach cancer	7.84e-06	9.17e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GSTM1—stomach cancer	7.74e-06	9.06e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—MAPK1—stomach cancer	7.64e-06	8.94e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ALOX5—stomach cancer	7.55e-06	8.83e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PPP2R1A—stomach cancer	7.53e-06	8.81e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—DPYD—stomach cancer	7.42e-06	8.69e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GSTP1—stomach cancer	7.38e-06	8.64e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—HMOX1—stomach cancer	7.28e-06	8.52e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ERCC2—stomach cancer	7.28e-06	8.52e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—KRAS—stomach cancer	7.21e-06	8.44e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—TYMS—stomach cancer	6.87e-06	8.04e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—MTHFR—stomach cancer	6.84e-06	8.01e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GSTM1—stomach cancer	6.79e-06	7.94e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PIK3CA—stomach cancer	6.63e-06	7.75e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GSTT1—stomach cancer	6.56e-06	7.68e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYP2A6—stomach cancer	6.49e-06	7.59e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—TP53—stomach cancer	6.41e-06	7.5e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ERCC2—stomach cancer	6.38e-06	7.47e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CAV1—stomach cancer	6.31e-06	7.39e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—AKR1C3—stomach cancer	6.31e-06	7.39e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—APOA1—stomach cancer	6.3e-06	7.37e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ENO1—stomach cancer	6.15e-06	7.2e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—HRAS—stomach cancer	6.13e-06	7.17e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.03e-06	7.06e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—MTHFR—stomach cancer	6e-06	7.02e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PPARG—stomach cancer	5.55e-06	6.5e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CAV1—stomach cancer	5.53e-06	6.47e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—APOA1—stomach cancer	5.52e-06	6.46e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CD44—stomach cancer	5.45e-06	6.38e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PIK3CA—stomach cancer	5.13e-06	6.01e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PPARG—stomach cancer	4.86e-06	5.69e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—NOS3—stomach cancer	4.77e-06	5.59e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PPP2R1A—stomach cancer	4.64e-06	5.43e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GSTP1—stomach cancer	4.55e-06	5.33e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—HMOX1—stomach cancer	4.49e-06	5.25e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ALB—stomach cancer	4.37e-06	5.12e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PTGS2—stomach cancer	4.37e-06	5.11e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—TYMS—stomach cancer	4.23e-06	4.95e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NOS3—stomach cancer	4.18e-06	4.9e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GSTM1—stomach cancer	4.18e-06	4.89e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ERCC2—stomach cancer	3.93e-06	4.6e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PTGS2—stomach cancer	3.83e-06	4.48e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—MTHFR—stomach cancer	3.69e-06	4.32e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CAV1—stomach cancer	3.41e-06	3.99e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—APOA1—stomach cancer	3.4e-06	3.98e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PPARG—stomach cancer	3e-06	3.51e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ALB—stomach cancer	2.69e-06	3.15e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PIK3CA—stomach cancer	2.69e-06	3.14e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NOS3—stomach cancer	2.58e-06	3.02e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PTGS2—stomach cancer	2.36e-06	2.76e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PIK3CA—stomach cancer	2.35e-06	2.75e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.45e-06	1.7e-05	CbGpPWpGaD
